Neurological disease presentation in HIV-infected individuals in the effective antiretroviral therapy era

被引：0
|
作者：
Fernando, S. [1 ]
Poynton, M. [1 ]
Everitt, A. [1 ]
Winston, A. [1 ]
机构：
[1] Imperial Coll London, London, England
来源：
HIV MEDICINE | 2014年 / 15卷
关键词：
D O I：
暂无
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：70 / 70
页数：1
相关论文
共 50 条
  • [21] Hospitalized HIV-Infected Patients in the Era of Highly Active Antiretroviral Therapy
    Metsch, Lisa R.
    Bell, Christine
    Pereyra, Margaret
    Cardenas, Gabriel
    Sullivan, Tanisha
    Rodriguez, Allan
    Gooden, Lauren
    Khoury, Nayla
    Kuper, Tamy
    Brewer, Toye
    del Rio, Carlos
    AMERICAN JOURNAL OF PUBLIC HEALTH, 2009, 99 (06) : 1045 - 1049
  • [22] Sarcoidosis in HIV-infected patients in the era of highly active antiretroviral therapy
    Foulon, G
    Wislez, M
    Naccache, JM
    Blanc, FX
    Rabbat, A
    Israël-Biet, D
    Valeyre, D
    Mayaud, C
    Cadranel, J
    CLINICAL INFECTIOUS DISEASES, 2004, 38 (03) : 418 - 425
  • [23] Cytomegalovirus infection in HIV-infected patients in the era of combination antiretroviral therapy
    R. Perello
    A. Vergara
    E. Monclus
    S. Jimenez
    M. Montero
    N. Saubi
    A. Moreno
    Y. Eto
    A. Inciarte
    J. Mallolas
    E. Martínez
    M. A. Marcos
    BMC Infectious Diseases, 19
  • [24] Audiological and electrophysiological alterations in HIV-infected individuals subjected or not to antiretroviral therapy
    Matas, Carla Gentile
    Samelli, Alessandra Giannella
    Leite Magliaro, Fernanda Cristina
    Segurado, Aluisio
    BRAZILIAN JOURNAL OF OTORHINOLARYNGOLOGY, 2018, 84 (05) : 574 - 582
  • [25] The effect of combined antiretroviral therapy on the overall mortality of HIV-infected individuals
    Ray, Maile
    Logan, Roger
    Sterne, Jonathan A. C.
    Hernandez-Diaz, Sonia
    Robins, James M.
    Sabin, Caroline
    Bansi, Loveleen
    van Sighem, Ard
    de Wolf, Frank
    Costagliola, Dominique
    Lanoy, Emilie
    Bucher, Heiner C.
    von Wyl, Viktor
    Esteve, Anna
    Casabona, Jordi
    del Amo, Julia
    Moreno, Santiago
    Justice, Amy
    Gouler, Joseph
    Lodi, Sara
    Phillips, Andrew
    Seng, Remonie
    Meyer, Laurence
    Perez-Hoyos, Santiago
    de Olalla, Patricia Garcia
    Herman, Miguel A.
    Phillips, A. N.
    Gilson, R.
    Easterbrook, P.
    Fisher, M.
    Gazzard, B.
    Johnson, M.
    Walsh, J.
    Leen, C.
    Orkin, C.
    Anderson, J.
    Pillay, D.
    Delpech, V.
    Schwenk, A.
    Dunn, D.
    Gompels, M.
    Hill, T.
    Porter, K.
    Babiker, A.
    Sabin, C.
    AIDS, 2010, 24 (01) : 123 - 137
  • [26] Niacin in HIV-infected individuals with hyperlipidemia receiving potent antiretroviral therapy
    Gerber, MT
    Mondy, KE
    Yarasheski, KE
    Drechsler, H
    Claxton, S
    Stoneman, J
    DeMarco, D
    Powderly, WG
    Tebas, P
    CLINICAL INFECTIOUS DISEASES, 2004, 39 (03) : 419 - 425
  • [27] Kaletra® (lopinavir/ritonavir), an antiretroviral therapy for HIV-infected individuals.
    Sham, HL
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2005, 229 : U1186 - U1186
  • [28] THE EFFECT OF COMBINED ANTIRETROVIRAL THERAPY ON THE OVERALL MORTALITY OF HIV-INFECTED INDIVIDUALS
    Ray, M.
    Hernan, M. A.
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2009, 169 : S132 - S132
  • [29] Serotonin syndrome in HIV-infected individuals receiving antiretroviral therapy and fluoxetine
    DeSilva, KE
    Le Flore, DB
    Marston, BJ
    Rimland, D
    AIDS, 2001, 15 (10) : 1281 - 1285
  • [30] HIV-infected individuals on long-term antiretroviral therapy are at higher risk for ocular disease
    Schaftenaar, E.
    Khosa, N. S.
    Baarsma, G. S.
    Meenken, C.
    Mcintyre, J. A.
    Osterhaus, A. D. M. E.
    Verjans, G. M. G. M.
    Peters, R. P. H.
    EPIDEMIOLOGY AND INFECTION, 2017, 145 (12): : 2520 - 2529
12345